Anders Hinsby

Directeur des opérations chez Muna Therapeutics ApS

Profil

Anders Mørkebjerg Hinsby founded Orphazyme A in 2009, where he worked as Chief Executive Officer from 2009 to 2019.
Dr. Hinsby also currently works at Intomics A, as Director from 2019, Vico Therapeutics BV, as Independent Director from 2020, WoB Holding ApS, as Member-Management Board, and Muna Therapeutics ApS, as Chief Operating Officer from 2021.
Dr. Hinsby also formerly worked at Dansk Biotek, as Chief Executive Officer & Director, F2G Ltd., as Non-Executive Director, Oz Holding ApS, as Director, BI Technology A, as Partner from 2009 to 2010, Technical University of Denmark, as Assistant Professor, Novo Ventures 1 A, as Principal, Bankinvest Biomedical Venture, as Principal, and InnovationsFonden, as Member.
Dr. Hinsby received his doctorate degree from the University of Copenhagen.

Postes actifs de Anders Hinsby

Sociétés	Poste	Début
WoB Holding ApS	Corporate Officer/Principal	-
Vico Therapeutics BV	Directeur/Membre du Conseil	01/10/2020
Muna Therapeutics ApS	Directeur des opérations	01/07/2021
Intomics A/S	Directeur/Membre du Conseil	01/01/2019

Anciens postes connus de Anders Hinsby

Sociétés	Poste	Fin
ORPHAZYME A/S	Directeur Général	01/10/2019
BI Technology A/S	Private Equity Investor	01/01/2010
Oz Holding ApS	Directeur/Membre du Conseil	-
InnovationsFonden	Corporate Officer/Principal	-
Dansk Biotek	Directeur Général	-

Formation de Anders Hinsby

University of Copenhagen

Doctorate Degree